← Leaderboards
Terrence Burke
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignCollaborationsStructureInhibitor/AntagonistReactionAffinityProteinsLaboratoriesPharmaceutical PreparationsNovel TherapeuticsPeptidesIntegraseExhibitsBaseEnzymesHiv IntegraseAntineoplastic AgentsComplexTyrosine Kinase InhibitorMalignant NeoplasmsSignal TransductionAcquired Immunodeficiency SyndromeHiv-1Analog
Grant awards (52)
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$1,761,393
ZIA · FY2025 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$587,130
ZIA · FY2025 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$1,663,314
ZIA · FY2024 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$554,437
ZIA · FY2024 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$1,491,988
ZIA · FY2023 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$497,330
ZIA · FY2023 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$1,362,849
ZIA · FY2022 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$454,284
ZIA · FY2022 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$810,475
ZIA · FY2021 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$810,475
ZIA · FY2021 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$1,133,603
ZIA · FY2020 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$485,830
ZIA · FY2020 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$1,028,940
ZIA · FY2019 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$440,975
ZIA · FY2019 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$842,594
ZIA · FY2018 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$361,111
ZIA · FY2018 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$796,553
ZIA · FY2017 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$341,380
ZIA · FY2017 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$977,073
ZIA · FY2016 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$418,745
ZIA · FY2016 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$818,870
ZIA · FY2015 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$350,944
ZIA · FY2015 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$862,629
ZIA · FY2014 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$369,699
ZIA · FY2014 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$747,535
ZIA · FY2013 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$320,372
ZIA · FY2013 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents$931,833
ZIA · FY2012 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$399,357
ZIA · FY2012 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents$965,045
ZIA · FY2011 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$413,591
ZIA · FY2011 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents$774,242
ZIA · FY2010 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$331,818
ZIA · FY2010 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents$952,152
ZIA · FY2009 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$408,065
ZIA · FY2009 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents$814,793
Z01 · FY2008 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$349,197
Z01 · FY2008 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signalling as Anticancer Agents$779,053
Z01 · FY2007 · CA · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$259,685
Z01 · FY2007 · CA · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signalling as An$0
Z01 · FY2006 · BC · contact PI
Design and Synthesis of HIV Integrase as Potential Anti-$0
Z01 · FY2006 · BC · contact PI
Inhibitors of Tyrosine Kinase-Dependent Signalling as An$0
Z01 · FY2005 · BC
Design and Synthesis of HIV Integrase as Potential Anti-$0
Z01 · FY2005 · BC
Design and Synthesis of HIV Integrase as Potential Anti-$0
Z01 · FY2004 · BC
Inhibitors of Tyrosine Kinase-Dependent Signalling as An$0
Z01 · FY2004 · BC
Inhibitors of Tyrosine Kinase-Dependent Signalling$0
Z01 · FY2003 · BC
Design and Synthesis of HIV Integrase as Potential Anti-$0
Z01 · FY2003 · BC
Design and Synthesis of HIV Integrase as Potential Anti-$0
Z01 · FY2002 · BC
Inhibitors of Tyrosine Kinase-Dependent Signalling as An$0
Z01 · FY2002 · BC
Design and Synthesis of HIV Integrase as Potential Anti-$0
Z01 · FY2001 · BC
Inhibitors of Tyrosine Kinase-Dependent Signalling as An$0
Z01 · FY2001 · BC
Inhibitors of Tyrosine Kinase-Dependent Signalling asAnticancer Agents$0
Z01 · FY2000 · BC
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs$0
Z01 · FY2000 · BC